Pfizer News

Jefferies Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsJan 13 08:31 ET

Pfizer's Strategic Initiatives and Growth Prospects Drive Buy Rating

TipRanksJan 13 08:07 ET

Bernstein Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Moomoo NewsJan 11 10:31 ET

Pfizer Is Maintained at Neutral by UBS

Dow JonesJan 8 10:09 ET

Pfizer Analyst Ratings

BenzingaJan 8 09:59 ET

UBS Maintains Pfizer(PFE.US) With Hold Rating, Cuts Target Price to $29

Moomoo NewsJan 8 07:34 ET

Truist Financial Maintains Pfizer(PFE.US) With Buy Rating, Maintains Target Price $32

Moomoo NewsJan 8 02:32 ET

Truist Financial Sticks to Its Buy Rating for Pfizer (PFE)

TipRanksJan 8 01:20 ET

TD Cowen Maintains Pfizer(PFE.US) With Hold Rating, Maintains Target Price $32

Moomoo NewsDec 22, 2024 23:31 ET

Pfizer: Navigating Revenue Challenges and Opportunities With a Hold Rating

TipRanksDec 20, 2024 13:00 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $29 to $33

Moomoo NewsDec 19, 2024 08:00 ET

Pfizer Price Target Cut to $32.00/Share From $36.00 by Truist Securities

Dow JonesDec 18, 2024 10:40 ET

Pfizer Analyst Ratings

BenzingaDec 18, 2024 10:29 ET

A Quick Look at Today's Ratings for Pfizer(PFE.US), With a Forecast Between $28 to $36

Moomoo NewsDec 18, 2024 08:00 ET

Truist Financial Gives a Buy Rating to Pfizer (PFE)

TipRanksDec 18, 2024 07:26 ET

Wells Fargo Adjusts Price Target on Pfizer to $28 From $27, Keeps Equalweight Rating

MT NewswiresDec 18, 2024 06:56 ET

Cautious Hold Rating for Pfizer Amidst Stable Near-Term Outlook and Long-Term Concerns

TipRanksDec 17, 2024 20:39 ET

Pfizer's Stable Outlook Amid Growth Challenges and Policy Risks Leads to Hold Rating

TipRanksDec 17, 2024 20:39 ET

Pfizer's Balanced Outlook: Hold Rating Amid Uncertainties and Growth Potential

TipRanksDec 17, 2024 20:39 ET

UBS Sticks to Its Hold Rating for Pfizer (PFE)

TipRanksDec 17, 2024 11:36 ET